The pharmacological treatment, mainly based on diuretics, of isolated systolic hypertension
(ISH) has recently been shown to reduce the risk of stroke and coronary heart disease in the …

The Systolic Hypertension in Europe (Syst-Eur) study investigated whether antihypertensive
treatment could decrease the risk of cardiovascular complications in elderly patients with …

The Syst-Eur study investigated whether active antihypertensive treatment could reduce
cardiovascular complications in elderly patients with isolated systolic hypertension …

Syst-Eur is a multicenter placebo-controlled outcome trial designed by the European
Working Pany on High Blood Pressure in the Elderly to investigate the effect of …

Isolated systolic hypertension (ISH) has proved to be a powerful predisposing factor for
cardiovascular diseases in the elderly. Recent placebo-controlled interventional trials such …

Introduction Hypertension is a major and modifiable risk factor for cardiovascular disease. Its
prevalence is rising as the result of population aging. Isolated systolic hypertension mostly …

Aims: Isolated systolic hypertension affects over 8 to 15% of all subjects older than 60 years.
In the elderly, systolic hypertension is the major modifiable cardiovascular risk factor. Three …

Systolic hypertension is a major health economy problem within our aging society.
Increased arterial stiffness is the vascular phenotype of systolic hypertension, especially of …

Isolated systolic hypertension affects 8% to 15% of all people older than 60 years of age. In
the elderly, systolic hypertension is the major modifiable cardiovascular risk factor. Three …

Hypertension is one of the main risk factors for cerebrovascular disease (stroke), coronary
artery disease (acute myocardial infarction), congestive heart failure (both systolic and …